Detail akcie Senzime online

Business Summary: Senzime AB (publ.) is a Sweden-based company engaged in the development, manufacture and marketing of biosensors for measuring metabolites in biological fluids, such as human blood and cell culture substrates for the pharmaceutical and healthcare segments. The Company focuses on the following application areas: medical diagnostic instruments, pharmaceutical industry, chemical processing, and food and beverage processing. As of December 31, 2011, the Company marketed three products, namely SENZ-100G, for continuous analysis of glucose in the fermentation solutions; SENZ-100L, for continuous analysis of lactate in fermentation solutions, and SENZ-200G, for continuous analysis of glucose in blood during intensive care.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Senzime AB (publ) revenues increased 70% to SEK75.7M. Net loss increased 2% to SEK94.5M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Financial Expenses increase from SEK688K to SEK18.8M (expense), Other operating income decrease of 27% to SEK14.9M (income).